OverviewSuggest Edit

Quidel is engaged in the development, manufacturing and marketing of diagnostic testing solutions. The Company sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers. Quidel's diagnostic solutions aid in the detection and diagnosis of critical diseases and other medical conditions, including infectious diseases, women's health, gastrointestinal diseases, autoimmune diseases, bone health and thyroid diseases.

TypePublic
Founded1979
HQSan Diego, US
Websitequidel.com
Employee Ratings2.4

Latest Updates

Employees (est.) (Dec 2019)1,250(+3%)
Job Openings81
Revenue (FY, 2019)$534.9 M(+3%)
Share Price (Nov 2020)$210.5 (-1%)
Cybersecurity ratingCMore

Key People/Management at Quidel

Douglas C. Bryant

Douglas C. Bryant

Director, President and Chief Executive Officer
Ratan Borkar

Ratan Borkar

SVP, International Commercial Operations
Robert J. Bujarski

Robert J. Bujarski

Chief Operating Officer
Matthew W. Strobeck

Matthew W. Strobeck

Director
Michael D. Abney

Michael D. Abney

SVP, North American Sales & Distribution
Randall J. Steward

Randall J. Steward

Chief Financial Officer
Show more

Quidel Office Locations

Quidel has offices in San Diego, Athens, Beverly, Kornwestheim and in 1 other location
San Diego, US (HQ)
12544 High Bluff Dr
Athens, US
2005 E State St
Athens, US
2005 E State St #100
Beverly, US
500 Cummings Center #5550
San Diego, US
10165 McKellar Ct
San Diego, US
9975 Summers Ridge Rd
Show all (9)

Quidel Financials and Metrics

Quidel Revenue

Embed Graph
View revenue for all periods
Quidel's revenue was reported to be $534.89 m in FY, 2019
USD

Revenue (Q3, 2020)

476.1m

Gross profit (Q3, 2020)

383.6m

Gross profit margin (Q3, 2020), %

80.6%

Net income (Q3, 2020)

232.3m

EBIT (Q3, 2020)

308.0m

Market capitalization (12-Nov-2020)

8.9b

Closing stock price (12-Nov-2020)

210.5

Cash (30-Sept-2020)

77.5m

EV

8.9b
Quidel's current market capitalization is $8.9 b.
USDQ2, 2011

Financial Leverage

1.4 x
Show all financial metrics

Quidel Operating Metrics

FY, 2016

Facilities

2
Show all operating metrics

Quidel Revenue Breakdown

Embed Graph

Quidel revenue breakdown by geographic segment: 83.0% from United States and 17.0% from Other

Quidel Cybersecurity Score

Cybersecurity ratingPremium dataset

C

79/100

SecurityScorecard logo

Quidel Environment, Social & Governance (ESG) Ratings

CSRHub ESG ratingPremium dataset

40-49

out of 100

CSRHub logo

Quidel Online and Social Media Presence

Embed Graph

Quidel News and Updates

Plexus Announces Manufacturing Award for the Quidel Sofia®2 Fluorescent Immunoassay Analyzer

NEENAH, Wis., Sept. 28, 2020 (GLOBE NEWSWIRE) -- Plexus (NASDAQ: PLXS) announced today its partnership with Quidel Corporation (“Quidel”) in support of the Sofia®2 Fluorescent Immunoassay Analyzer. Plexus will provide Supply Chain and Manufacturing Solutions to Quidel, an industry leader in diagno…

Thinking about trading options or stock in GameStop, Fulgent Genetics, Inovio Pharmaceuticals, Quidel Corp, or United Airlines?

NEW YORK, Sept. 22, 2020 /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GME, FLGT, INO, QDEL, and UAL. Click a link below then choose between in-depth options trade idea report or a stock score report. Options Report – Ideal trade ideas on up to seven different...

Quidel Stock Looks Attractive After A Healthy Correction

Quidel stock has rallied 75% since late March (vs. about 53% for the S&P 500) to its current level near $154. The stock fell to a low of $88 in late March as a rapid increase in the number Covid-19 cases outside China resulted in heightened fears of an imminent global economic downturn...

Home Diagnostics Market Status – COVID to Make Big Changes in Estimates | Bionime, Quidel, Siemens, Abaxis

Home Diagnostics Comprehensive Study by Type (Cassette, Strip, Midstream, Digital Monitoring Instrument, Test Panel, Dip Card, Others), Distribution Channels (Offline, Online), Test Kit Type (Glucose Monitoring Devices, Pregnancy Tests, HIV, Ovulation Prediction, Cholesterol, Drug Abuse, Others) Pl…

Despite A 3x Move Quidel Stock Can Gain More

Despite a stellar 2.6x rise since the March 23 lows of this year, at the current price of around $230 per share we believe Quidel, best known for its diagnostic healthcare products, looks attractive and it has more room for growth.
Show more

Quidel Blogs

Quidel Reports Second Quarter 2019 Financial Results

SAN DIEGO --(BUSINESS WIRE)--Aug. 8, 2019-- Quidel Corporation (NASDAQ: QDEL), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today financial results for the second quarter ended June 30, 2019 .

Quidel to Hold Second Quarter 2019 Financial Results Conference Call on August 8th, 2019

Quidel to Hold Second Quarter 2019 Financial Results Conference Call on August 8th, 2019 Content Import Fri, 07/26/2019 - 18:00 Quidel to Hold Second Quarter 2019 Financial Results Conference Call on August 8th, 2019 July 26, 2019 at 6:00 PM EDT This release i…

Q2 2019 Quidel Corporation Earnings Conference Call

Q2 2019 Quidel Corporation Earnings Conference Call marco.guevara@… Fri, 07/26/2019 - 15:12 Q2 2019 Quidel Corporation Earnings Conference Call Display "add to calendar" true Event Type Earnings Conference Call Click here for …

Kathy P. Ordoñez

Kathy P. Ordoñez marco.guevara@… Wed, 06/26/2019 - 09:18 Kathy P. Ordoñez Former officer of Pacific Biosciences, RainDance Technologies, Inc., Quest Diagnostics, Inc., Celera, and Hoffman-La Roche

Quidel Receives 510(k) Clearance for Quidel Triage® TOX Drug Screen, 94600 Toxicology Test for Use With Quidel’s Triage® MeterPro Instrumented System

Quidel Receives 510(k) Clearance for Quidel Triage® TOX Drug Screen, 94600 Toxicology Test for Use With Quidel’s Triage® MeterPro Instrumented System Content Import Wed, 06/19/2019 - 18:00 Quidel Receives 510(k) Clearance for Quidel Triage® TOX Drug Screen, 94600 Toxicology Test for Use Wi…

Quidel Announces Private Exchange Transactions

Quidel Announces Private Exchange Transactions Content Import Tue, 06/04/2019 - 18:00 Quidel Announces Private Exchange Transactions June 4, 2019 at 6:00 PM EDT This release is a backfill from a News Wire General SAN DIEGO--(BUSINESS …

Quidel Frequently Asked Questions

  • When was Quidel founded?

    Quidel was founded in 1979.

  • Who are Quidel key executives?

    Quidel's key executives are Douglas C. Bryant, Ratan Borkar and Robert J. Bujarski.

  • How many employees does Quidel have?

    Quidel has 1,250 employees.

  • What is Quidel revenue?

    Latest Quidel annual revenue is $534.9 m.

  • What is Quidel revenue per employee?

    Latest Quidel revenue per employee is $427.9 k.

  • Who are Quidel competitors?

    Competitors of Quidel include CareView Communications, Halfpenny Technologies and Appistry.

  • Where is Quidel headquarters?

    Quidel headquarters is located at 12544 High Bluff Dr, San Diego.

  • Where are Quidel offices?

    Quidel has offices in San Diego, Athens, Beverly, Kornwestheim and in 1 other location.

  • How many offices does Quidel have?

    Quidel has 9 offices.